Kelyniam Global, Inc. (KLYG)
OTCMKTS · Delayed Price · Currency is USD
0.2200
+0.0105 (5.01%)
Oct 29, 2025, 3:20 PM EDT
Kelyniam Global Revenue
In the year 2023, Kelyniam Global had annual revenue of $2.67M, down -11.44%. Kelyniam Global had revenue of $930.77K in the quarter ending December 31, 2023, with 14.08% growth.
Revenue
2.67M
Revenue Growth
-8.03%
P/S Ratio
4.14
Revenue / Employee
133.62K
Employees
20
Market Cap
11.07M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 2.67M | -345.24K | -11.44% |
| Dec 31, 2022 | 3.02M | 353.17K | 13.25% |
| Dec 31, 2021 | 2.66M | 152.33K | 6.06% |
| Dec 31, 2020 | 2.51M | 328.98K | 15.07% |
| Dec 31, 2019 | 2.18M | 59.43K | 2.80% |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Jushi Holdings | 256.36M |
| Glass House Brands | 221.55M |
| Elite Pharmaceuticals | 105.45M |
| Silence Therapeutics | 27.17M |
| Nuo Therapeutics | 1.95M |
| Northwest Biotherapeutics | 1.09M |
Kelyniam Global News
- 5 weeks ago - Kelyniam Global, Inc. Receives FDA Clearance for Innovative Fusion™ BCP-PEEK Implant - PRNewsWire
- 6 weeks ago - Kelyniam Global Inc. to Present at the Life Sciences Virtual Investor Forum September 18th - PRNewsWire
- 7 weeks ago - Commitment to Investor - PRNewsWire
- 2 months ago - Kelyniam Global Announces Q2 2025 Financial Results - PRNewsWire
- 6 months ago - Kelyniam Global Announces Q1 2025 Financial Results and Strategic Partnership - PRNewsWire
- 8 months ago - KELYNIAM ACHIEVES RECORD REVENUE & PROFITABILITY FOR 2024 - PRNewsWire
- 11 months ago - Kelyniam Global, Inc., ("KLYG") Announces Private Investment to Public Entity ("PIPE") Closure of Securities Offering - PRNewsWire
- 1 year ago - Kelyniam Global Releases Q3 Financials, Strong Performance Continues - PRNewsWire